AzTrials
AzTrials

HealthyNCT03116581

Altruistic Decisions

A study testing Behavior, fMRI (functional Magnetic Resonance Imagery) and MEG (MagnetoEncephaloGraphy) in people with Healthy, run by Hospices Civils de Lyon at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The study aimed to understand how payoffs for others influence perceptual decision making. The research consists in testing how varying monetary payoffs for another modify the perceptual decision making processes. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Behavior, fMRI (functional Magnetic Resonance Imagery) and MEG (MagnetoEncephaloGraphy)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
159 participants
Where
1 siteFrance
Study dates
3 Feb 2014to 22 Jul 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Aged between 18 and 35
  • Right-handed
  • French
  • Normal vision or corrected by contact lenses

Who cannot join

  • Contraindications to the MEG examination
  • Presence of a perceptual disorder (vision) or motor impairing the capacity to carry out the tasks requested (including dyschromatopsia and achromatopsia).
  • Taking of medical treatment in progress (excluding contraceptive pill).
  • Known neurological or psychiatric history or disorders.
  • Participants in an exclusion period for any other research.
  • Participants who do not benefit from social protection.
Show all 9Show fewer
  • Participants refusing to be informed of the results of the medical examination.
  • Participants who refuse to be informed of the possible detection of an anomaly.
  • Participants with MRI contraindications

Trial locations and contacts

1 site in 1 country.

France1 site
  • CH le Vinatier

    Bron, 69677

Other trials in France

About this study

Official title: Study on the Parameters That Influence Perceptual Decisions

The study aimed to understand how payoffs for others influence perceptual decision making. The research consists in testing how varying monetary payoffs for another modify the perceptual decision making processes. The use of drift diffusion models on a random dots task enable the characterization of the decision parameter(s) that are modulated when a decision is made to win payoffs for others as compared to decisions for self-benefits. Once the parameter revealed through behavioral experiment, neuroimaging is applied to find the neural correlates of the effects of taking others into account in the decision making process.

Conditions
Healthy
Being tested
Behavior, fMRI (functional Magnetic Resonance Imagery), MEG (MagnetoEncephaloGraphy)
Keywords
Perceptual Decision, Social Cognition, Motivation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BehaviorOther

    Random-dots tasks: dots appear and move, most have a random trajectory but a given proportion of them move coherently to the same direction.

    • Vicarious reward Each trial begins with a cue, showing 'me' or 'him' and filled rectangle filled proportionally to the payoff. The cue and the square are depicted in yellow (oneself) or blue (other), depending on the beneficiary. The moving dots are then presented and the subjects respond. At the end of dots motion, the feedback is presented. If the response was correct, a pile of coins proportional to the payoff is shown. For incorrect responses and misses, a red-colored cross is displayed.
    • Audience effect Each trial begins with the display of two eyes (public) or a padlock (private). The moving dots are shown and the participant answers. Audience condition changes the information available on accuracy when submitting comments. In the observed condition, an arrow shows the response. In the observed condition, no feedback is displayed.
  • fMRI (functional Magnetic Resonance Imagery)Other

    Both behavioral task (audience effect and vicarious reward) will be studied in fMRI (functional Magnetic Resonance Imagery). The same paradigms used in the behavioral experiment will be adapted for fMRI.

    Audience Effect experiment: trials will last for 10 seconds maximum. With 80 trials for each condition (public easy, public difficult, private easy and private difficult), the task will count a total of 320 trials and have a 54 minutes duration, in 3 runs of 17 minutes each.

    Vicarious Reward experiment: trials will have a 10 seconds maximum duration. Using 40 trials for each condition (other low payoff, other high payoff, self low payoff, self high payoff, control condition), the task will have a total of 200 trials and last for 54 minutes, in 6 runs of 9 minutes each.

  • MEG (MagnetoEncephaloGraphy)Other

    Both behavioral task (audience effect and vicarious reward) will be studied in MEG (MagnetoEncephaloGraphy). The same paradigms used in the behavioral experiment will be used in MEG.

    Audience Effect experiment: trials will last for 7 seconds maximum. With 100 trials for each condition (public easy, public difficult, private easy and private difficult), the task will count a total of 400 trials and have a 47 minutes duration. Every 100 trials (about 12 minutes of tasks), a break will be proposed to the participants.

    Vicarious Reward experiment: trials will have a 7.2 seconds maximum duration. Using 75 trials for each condition (other low payoff, other high payoff, self low payoff, self high payoff, control condition), the task will have a total of 375 trials and last for 45 minutes. Every 125 trials (every 15 minutes), a break will be proposed to the participants.

Study groups in NCT03116581
Study groupRoleWhat they receive
Vicarious rewardOtherIf a decision influences the well-being of another (through monetary payoff), the decision making processes should differ from a decision that would influences only oneself. The difference will be reflected in the reaction-times and in the accuracy of the response to the task. The drift diffusion models care then used to estimate le decision parameter in each condition and understand which parameter is influenced by the beneficiary of the payoff associated with a decision. Once the decision parameter characterized with behavioral experiment, the study aims to better understand the neural network sustaining the influence of others on the decision making process, by assessing the neural activity related to the decision making processes. Also, the research compares how the brain responses for payoff for others and payoffs for oneself, specially to confirm that these responses are located in different areas of the Anterior cingulate Cortex.
Receives: Other: Behavior; Other: fMRI (functional Magnetic Resonance Imagery); Other: MEG (MagnetoEncephaloGraphy)
Audience effectOtherIn order to clarify the complex changes in the decision-making processes induced by simple observation by others (audience) , the experiment have two levels of difficulty . These levels of difficulty will be determined in such a way as to achieve better 'public' performance than 'private' when the task is easy (high level of consistency) and poor performance when the task is difficult (low level of coherence) As described in the literature in psychology. Drift diffusion models will be used to better understand the variations in performance, to decipher between a modulation of the diffusion velocity and or of the decision threshold. This study will help characterize how observation by others modulates performance. Once the decision parameter characterized with behavioral experiment, the study aims to better understand the neural network sustaining the impact of observation by others on the decision making process.
Receives: Other: Behavior; Other: fMRI (functional Magnetic Resonance Imagery); Other: MEG (MagnetoEncephaloGraphy)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Modulation of the decisional parameter by the payoff conditions

    behavioral data (reaction-times and accuracy) are collected and the decision parameter can be estimated from them using Drift Diffusion Models

    Measured: 1 hour

  2. Modulation of the decisional parameter by the beneficiary conditions

    behavioral data (reaction-times and accuracy) are collected and the decision parameter can be estimated from them using Drift Diffusion Models

    Measured: 1 hour

Secondary outcomes (3)
  1. Event-Related potentials

    study of the time-locked brain activity

    Measured: 1 hour

  2. Time-frequency brain responses

    study of the oscillatory activity elicited in the brain

    Measured: 1 hour

  3. BOLD

    Variation of the blood-oxygen-level dependent (BOLD) signal

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2017
  2. Study start3 Feb 2014
  3. Primary completion22 Jul 2016
  4. Study completion22 Jul 2016

Why it stopped: Insufficient on-site staff to manage study

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
159 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03116581
Sponsor's protocol ID
69HCL16_0680
Status last verified
Nov 2017
First submitted
7 Mar 2017
Last updated
28 Nov 2017
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Behavior, fMRI (functional Magnetic Resonance Imagery) and MEG (MagnetoEncephaloGraphy) in people with Healthy, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 28 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Insufficient on-site staff to manage study). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Modulation of the decisional parameter by the payoff conditions (time frame: 1 hour). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in